The results of IHC analyses revealed that the tumor tissues derived from the “Panc 02 + rHSP90α-treated RAW264.7” grafts contained more CD163+ cells but significantly reduced levels of CD4+ T-cells when compared with the tumor masses taken from other groups of mice (Figure 5C). This evidence concerns the gene CD163 and neoplasm.